Followers | 240 |
Posts | 12051 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Tuesday, August 16, 2022 7:22:03 PM
Supports Glass Lewis and ISS WITHHOLD Recommendations
Believes a Change in Board Composition is Necessary to Unlock Shareholder Value
OLD GREENWICH, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Star Equity Fund, LP (“Star Equity Fund” or “we”), a 5% shareholder of Gyrodyne, LLC (Nasdaq: GYRO) (“Gyrodyne” or the “Company”), advocates for improved corporate governance and enhanced shareholder value at its portfolio companies. To that end, Star Equity Fund previously issued two press releases detailing our concerns about Gyrodyne. Recent reports from the proxy advisory firms Glass Lewis & Co., LLC (“Glass Lewis”), and Institutional Shareholder Services (“ISS”) reaffirm Gyrodyne’s continued track record of poor corporate governance. We believe the apathy of Gyrodyne’s incumbent board of directors (the “Board”) has been a root cause of shareholder value destruction.
We have already identified many aspects of poor corporate governance concerning the Gyrodyne Board, as disclosed in our previous press releases dated March 23, 2022, and August 1, 2022. Specifically:
In March, we emphasized our concerns with the Board’s bonus plan in the event of liquidation and announced our intent to nominate director candidates for the upcoming election. To our disappointment, and likely as a response to our press release, Gyrodyne’s Board amended the bonus plan in its 10-Q filed on May 11, 2022, to restrict its alteration and ensure their compensation even in the case of failed reelection. Additionally, Gyrodyne rejected our request to waive the requirement of holding $2,000 worth, or 1%, of common stock for at least a year.
In our August press release, we announced our intentions to vote WITHHOLD on the re-election of Paul L. Lamb and Richard B. Smith to the Board. In this release we expressed our views that the Board is running the Company for their personal benefit, collecting compensation while delaying the dissolution of the Company, guaranteeing an exorbitant bonus plan, having no requirement for executive ownership in the company, and not responding to shareholders’ continued concerns of poor corporate governance.
Glass Lewis and ISS independently raised similar concerns:
Both Glass Lewis and ISS independently came to many of the same conclusions of poor corporate governance at Gyrodyne within their recently issued reports, published on August 1, 2022, and August 5, 2022, respectively. These reports analyzed the proposals for consideration at the upcoming Gyrodyne annual meeting of shareholders including: the election of directors Paul L. Lamb and Richard B. Smith, the advisory vote on Executive Compensation, and the ratification of an independent auditor. Both firms recommended shareholders vote WITHHOLD on the re-election of Paul L. Lamb and Richard B. Smith and AGAINST the proposal to ratify the executive officers’ compensation, in line with our announced intentions.
Concerning the proposal for the election of directors, Glass Lewis reported that both incumbent nominees carried “ongoing compensation concerns” and displayed “insufficient response to shareholder dissent.” As both directors are members of the compensation committee, Glass Lewis suggested they “may not be effectively serving shareholders in this regard.” As they noted in their 2021 report on Gyrodyne, a substantial 37.3% of the votes were cast against last year’s executive compensation proposal. In addition to our protests, the Board has taken no action to reflect the large amount of shareholder dissent around this issue, among others, displaying entrenchment and indifference toward shareholders. ISS similarly suggested that the compensation committee “demonstrated poor responsiveness to shareholder concerns.” Additionally, both firms noted that the Board currently lacks gender diversity and appears to lack racial/ethnic diversity.
Regarding the advisory vote to ratify the executive compensation program, both firms identified poor governance practices. ISS reemphasized the board’s indifference toward shareholder concern on the historical say-on-pay votes, citing persistent low support of only 59.2% votes cast in 2020 and 60.3% votes cast in 2021. Glass Lewis noted a change of control provision within this proposal which would allow for the acceleration of certain vested outstanding equity rewards upon change of control, discouraging potential buyers and/or lowering the potential premium paid to investors in this scenario. They noted a lack of share ownership requirements among executives (who collectively own 0%) as well as minimal ownership among directors, failing to align the Board with the long-term interests of shareholders. Furthermore, they felt that the retention bonus plan allowing for non-executive director participation conflates the perspectives of independent directors and executives.
Star Equity Fund believes significant change to the Board is needed to unlock shareholder value.
In light of these reports and our recent press releases surrounding Gyrodyne’s poor corporate governance, we believe significant change to the Board is necessary to unlock shareholder value and to better align the Board’s interests with shareholders. We maintain our intention to vote WITHHOLD on the election of the two incumbents and AGAINST the executive compensation plan and continue to push for the interests of all shareholders of Gyrodyne.
About Star Equity Fund, LP
Star Equity Fund, LP is an investment fund managed by Star Equity Holdings, Inc. Star Equity Fund seeks to unlock shareholder value and improve corporate governance at its portfolio companies.
About Star Equity Holdings, Inc.
Star Equity Holdings, Inc. is a diversified holding company with three divisions: Healthcare, Construction, and Investments.
https://www.globenewswire.com/news-release/2022/08/16/2499091/0/en/Star-Equity-Fund-Responds-to-Proxy-Reports-for-Gyrodyne-LLC.html
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent GYRO News
- GYRODYNE ANNOUNCES CLOSING OF SUCCESSFUL, OVERSUBSCRIBED RIGHTS OFFERING • GlobeNewswire Inc. • 03/08/2024 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 06:59:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:55:19 PM
- GYRODYNE ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING • GlobeNewswire Inc. • 02/06/2024 02:25:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/06/2024 11:01:08 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/01/2024 10:14:29 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/26/2024 05:20:17 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/23/2024 02:48:21 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 01/22/2024 04:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 04:14:07 PM
- GYRODYNE ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERING • GlobeNewswire Inc. • 01/22/2024 04:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:14:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/29/2023 06:21:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 02:54:22 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 11/21/2023 10:09:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:09:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 06:03:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/12/2023 08:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 09:12:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/07/2023 08:18:41 PM
- Gyrodyne Announces Agreement with Star Equity Fund • PR Newswire (US) • 09/06/2023 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/22/2023 08:55:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2023 08:55:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 09:28:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/01/2023 08:30:50 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM